Olmesartan Plus HCT EG 20 mg - 12.5 mg (olmesartan + hydrochloorthiazide) · CNK 3532520

Product information

Product name
Olmesartan Plus HCT EG 20 mg - 12.5 mg
Pack
28
Active ingredient
olmesartan + hydrochloorthiazide
CNK Code
3532520
Availability score
0 / 10
Historic availability score
Locked

Product properties

CAS code
144689-63-4
ATC code
C09DA08
Company
EG
Pharmaceutical form
Film-coated tablet
Ex-factory price
€6.86
Authorisation number
BE501182
GTIN
05400581004506
Delivery mode
M1
Delivery environment
Public
CTI Extended
501182-03

Pharmacist Assessment

Assessment title
Commercialization officially ended — no stock
Assessment description

SAM has flagged this product as commercially stopped (reason: Replacement by another medicinal product/pack) and no stock is available from wholesalers. Switching to an alternative is necessary.

Recommended alternative

Assessment alternative
Belsar Plus 20 mg - 12.5 mg (CNK 2363109) — Score: 8.35/10

Equivalent products

Tier A: Direct equivalents

…

Tier B: Galenic alternatives

…

Tier C: Strength alternatives

…

Tier D: ATC equivalents (parallel import)

…

Tier E: Active substances (magistral)

…

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives
Parallel import available 1 Magistral alternative available 2

Status history (PharmaStatus)

Commercialization stopped Active
- present

Replacement by another medicinal product/pack

Alternative available

Composition

4 ingredients

Ingredients
Substance Type Strength CAS
Substance
Olmesartanmedoxomil
Type
Active ingredient
Strength
20 mg
CAS
144689-63-4
Substance
Hydrochloorthiazide
Type
Active ingredient
Strength
12.5 mg
CAS
58-93-5
Substance
Lactosemonohydraat
Type
Excipient
Strength
CAS
Substance
Lactosemonohydraat
Type
Excipient
Strength
103 mg
CAS

Additional information

Leaflet
Download leaflet
SPC
Download SPC
BCPI
View on BCPI
PharmaStatus
View on PharmaStatus

Availability statistics

Current status
Commercialization stopped
Days unavailable (last year)
364 days
Number of status changes
1
Active supply problems
0
Last change
10/07/2025